Hospital-acquired Pneumonia Clinical Trial
Official title:
Prospective Observational Post Marketing Surveillance Study to Observe Safety and Effectiveness of Zavicefta IV
The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients with difficult types of infections in the abdomen, urinary tract and pneumonia which could have come from hospitalizations. This study was required by the Ministry of Food and Drug Safety (MFDS) of Korea's regulations.
The objective of this study is to determine any problems or questions associated with Zavicefta after marketing, with regard to the following clauses under conditions of general clinical practice, in compliance with the regulation "Re-examination Guideline of New Drugs". 1. Serious adverse event/adverse drug reaction 2. Unexpected adverse event/adverse drug reaction that have not been reflected in the approved drug label. 3. Known adverse drug reaction 4. Non-serious adverse drug reaction 5. Other safety and effectiveness information As required for any new medication approved by Ministry of Food and Drug Safety (MFDS), information on safety and effectiveness of new medication should be researched on certain number of subjects taking the drug in the setting of routine practice during the initial 6 years after the approval of new drug. This reserach shall begin after approval of marketing in Korea by MFDS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01266863 -
E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis.
|
N/A | |
| Not yet recruiting |
NCT06168734 -
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
|
Phase 3 | |
| Not yet recruiting |
NCT01940731 -
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
|
Phase 2 | |
| Not yet recruiting |
NCT06028217 -
Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
|
||
| Completed |
NCT01561469 -
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
|
N/A | |
| Terminated |
NCT00543608 -
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
|
Phase 2 | |
| Enrolling by invitation |
NCT04055922 -
Comparison of Solid Organ Transplant
|
||
| Completed |
NCT04403971 -
0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
|
N/A | |
| Completed |
NCT04774094 -
Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
|
Phase 4 | |
| Completed |
NCT05060718 -
HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies
|
||
| Active, not recruiting |
NCT05785442 -
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
|
Phase 2 | |
| Completed |
NCT04700202 -
Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
|
||
| Not yet recruiting |
NCT05418517 -
Hospital Acquired Pneumonia in Temporary Tracheostomy
|
||
| Recruiting |
NCT04381247 -
Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway
|
||
| Recruiting |
NCT05483309 -
Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia.
|
N/A | |
| Completed |
NCT04937075 -
Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
|
||
| Completed |
NCT03496220 -
Effect of Angulus on Patient-elevation Compliance
|
N/A | |
| Not yet recruiting |
NCT05914584 -
"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
|
Phase 2/Phase 3 | |
| Completed |
NCT05663905 -
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
|
Phase 4 | |
| Terminated |
NCT03361085 -
Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)
|
N/A |